CRISPR Therapeutics AG
A gene-editing company developing gene-based medicines for serious diseases.
CRSP | US
Overview
Corporate Details
- ISIN(s):
- CH0334081137
- LEI:
- Country:
- United States of America
- Address:
- BAARERSTRASSE 14, 0 ZUG
- Website:
- https://crisprtx.com/
- Sector:
- Manufacturing
Description
CRISPR Therapeutics AG is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. The company leverages this technology to make precise, directed changes to genomic DNA. As a pioneer in the field, CRISPR Therapeutics has established a diverse portfolio of therapeutic programs across several disease areas, including hemoglobinopathies (such as sickle cell disease and beta-thalassemia), immuno-oncology, regenerative medicine, and cardiovascular disease. The company was one of the first to advance a CRISPR-based therapy into clinical trials and receive regulatory approval, aiming to create potentially curative treatments for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CRISPR Therapeutics AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CRISPR Therapeutics AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CRISPR Therapeutics AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
